We describe the development and performance of a secondgeneration enzyme immunochromatography method for visually quantifying theophylline in whole blood without the use of instrumentation. We have developed the novel concept of an internal chemical clock reaction to combine the capillarymigration and color-generation protocol of the two-step immunochromatographic assay into a single-step, simultaneous protocol. The two assay components are (a) chromatographic paper to which glucose oxidase (EC 1.1.3.4) and monoclonal antibody to theophylline have been immobilized, and (b) an enzyme reagent consisting of glucose, dicarboxidine, ascorbate, and theophylline-Iabeled horseradish peroxidase (EC 1.11.1.7). The ascorbate acts as an internal clock by inhibiting premature color formation until the ascorbatehas been completely consumed in the peroxidasemediated reaction. Color is then generated rapidly, producing a clearly visible front on the paper. Performance evaluations of the 20-mm one-step assay show very good precision, analytical recovery, specificity, and accuracy. This simplified protocol is reliable and convenient for therapeutic drug monitoring in the physician's office. In addition, such tests should have a short turnaround time to allow physicians to regulate therapeutic dosage and provide counselling while the patient is still in the office (1).
ish peroxidase (EC 1.11.1.7). The ascorbate acts as an internal clock by inhibiting premature color formation until the ascorbatehas been completely consumed in the peroxidasemediated reaction. Color is then generated rapidly, producing a clearly visible front on the paper. Performance evaluations of the 20-mm one-step assay show very good precision, analytical recovery, specificity, and accuracy. This simplified protocol is reliable and convenient for therapeutic drug monitoring in the physician's office. Satellite and physician's office testing (si'o'r) is a rapidly expanding area well suited for therapeutic drug monitoring.
Analytical techniques
designed for the sir environment must be accurate, precise, and simple because office laboratory personnel will usually have less formal laboratory training than their clinical laboratory counterparts.
In addition, such tests should have a short turnaround time to allow physicians to regulate therapeutic dosage and provide counselling while the patient is still in the office (1).
We have recently described a new technology (AccuLevelTM) with unique features well suited to the sro'r environment (2) . This enzyme immunochromatographic technique (2) combines some of the properties of heterogeneous immunocapillary migration (3) with homogeneous enzyme channelling immunoassay (4) . The enzyme imntunochromatographic assay approach has been successfully applied for the measurement of various therapeutic drugs such as theophylline (2), phenobarbital (5), phenytoin (6) , and carbamazepine (7) .
The original AccuLevel format required a two-step protocol. Whole blood was mixed with an enzyme reagent containing an enzyme corjugate [horseradish peroxidase (EC 1.11.1.7; HRP)-hapten]
and glucose oxidase (EC 1.1.3.4). One end of a paper strip containing a preparation of specific Syntex Diagnostics Division, 900 Arastradero, Palo Alto, CA
94304.
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monoclonal antibody was then placed in the enzyme reagent. As the liquid components were drawn up the test strip by capillary action, the test strip absorbed a finite and reproducible volume of the analyte/enzyme reagent mixture. During this process, the analyte of interest (theophylline) and the HRP-hapten conjugate were immunospecifically bound by the immobilized antibody. In the absence of analyte, the HRP-hapten conjugate, which was included in very low concentrations (as a tracer), was bound by the immobilized antibody near the bottom of the test strip. As the concentration of analyte is increased, the analyte and the HRP-hapten conjugate competed for the available antibody-binding sites, so that the HRP-hapten conjugate and analyte migrated further up the strip before being entirely bound by the immobilized antibody, the height to which the conjugate moved being proportional to the analyte concentration. During this movement ("wicking"), the glucose oxidase was uniformly distributed along the entire length of the test strip. The test strip was then fully immersed in the developer solution, which contained glucose and chromogenic substrate for peroxidase.
Color developed only where conjugate had been immunospecifically bound by the antibody. The height of the resulting colored area was proportional to the concentration of the drug. In the two-step protocol, the immunological event was separated from the color-generation event by virtue of the fact that there was no glucose substrate for the glucose oxidase in the enzyme reagent. Here we describe a secondgeneration enzyme immunochromatographic assay based on a simple, one-step protocol. In this simplified assay protocol, one only adds a blood sample, places the test strip in enzyme/developer reagent, and reads the result after an appropriate incubation. All advantages of the assay methodology for enzyme immunochromatography are maintained: The assay is quantitative and factory calibrated, requires no instruments, and utilizes whole blood. The one-step protocol improves the convenience of the visual enzyme immunochromatographic assay.
Principle of the Internal Chemical Clock
If the enzyme and developer reagents are to be combined into one vial, at least one of the components of the colorgeneration system has to be absent from the enzyme/ was that the colored products, formed during the wicking phase, did not localize instantly and were instead carried along by the moving fluid, resulting in a smeared pattern.
To obviate the problem of a diffuse front and allow a onestep assay, we envisioned an "internal chemical clock" reaction that would temporally separate the color-generation reactions from the immunological-binding and capillary-migration events. Our objective was to prevent color formation until the wicking phase was complete and the fluid movement had stopped. One way to design an internal clock reaction is to add a substance to the reaction mixture that (a) temporarily prevents formation of the colored product and (b) is itself consumed by the reaction. No color would therefore form until the added substance was completely consumed, and the delay time in the color reaction would be proportional to the initial concentration of this additive. Here we illustrate with theophylline the development and performance of a single-step assay utilizing the concept of a chemical clock.
Materials and Methods

Materials
HRP (EC 1.11.1.7) was purchased from Toyobo, Osaka, Japan; glucose oxidase (Type V) and theophylline from Sigma Chemical Co., St. Louis, MO 63178; L-ascorbic acid from Eastman Kodak, Rochester, NY 14650; and dicarboxidine dihydrochioride [DCD; (y,y'-4,4'-diamino-3,3-biphenylene dioxyl)dibutyric acid] was a product of Kabi, Stockholm, Sweden. The paper support in the test strip was Grade 31ET Chrom (Whatman Inc., Clifton, NJ 07014). All other chemicals were reagent grade and were used without further purification.
Monoclonal anti-theophylline antibody and glucose oxidase were immobilized onto activated paper, to serve as the test strips, as previously described (2). The previously described (2) .
Assay Components and Protocol
The 
Results and Discussion
Ascorbate as a Chemical Clock: Solution Studies Although DCD is a benzidine derivative, its properties as a HRP substrate have not been extensively investigated.
Because use of different experimental conditions leads to different colored products (10) , several chemical intermediates may exist between the colorless starting material and the 440-nm-absorbing product formed at neutral pH. Identification of a compound that reacts with one of the substrates or one of the putative intermediates, preventing the formation of the colored product, might prove useful in preventing premature color development in the one-step enzyme immunochromatographic assay. As a candidate for a "chemical clock" in the HRP-mediated oxidation of DCD, we selected ascorbate, a powerful reducing agent that has been implicated as an interferent in peroxidase-coupled reactions.
A comparison of the solution-phase absorption spectra for the HRP-catalyzed oxidation of DCD in the presence and absence of ascorbate is shown in Figure 2 . In the absence of ascorbate, absorbance rapidly increases with an absorbance maximum at 440 nm. In the presence of ascorbate, however, there was a significant lag (2 mm) in the oxidation of DCD to the 440-nm-absorbing product. Although the presence of ascorbate meant that attaining the same absorbance value took longer, ascorbate has no effect on the shape of the absorption spectrum for oxidized DCD, indicating that the same product(s) is formed whether ascorbate is present or not.
Because of the delay in the oxidation of DCD to colored product in the presence of ascorbate, we performed further experiments to investigate the kinetics and mechanism of the ascorbate effect. As reported elsewhere (8) , the delay time in the appearance of the colored product, after the lag phase, was directly proportional to the amount of ascorbate present in the solution, from 0 to 0.32 mmol/L. However, the rate of the appearance of the colored product, after the lag phase, was essentially independent of the initial concentration of ascorbate (0.04 A/mm) (8). We also investigated the effect of varying the other components of the assay on both the lag time and on the rate of the reaction. We found that at a fixed concentration of ascorbate, increasing the concentration of HRP or DCD shortened the delay time for the appearance of the colored product and increased the rate of its appearance (8) . Hydrogen peroxide behaves slightly differently: increasing the concentration of hydrogen peroxide decreased the time lag in the formation of colored product but, over the concentration range studied, the rate of formation did not continue to increase with increasing concentration.
These results were not unexpected and can be simply explained as manifestations of the kinetics of enzyme-catalyzed reactions. We also examined the effect of ascorbate addition on the colored product of the DCD oxidation catalyzed by HRP. As Figure 3 shows, once the colored product has been formed, ascorbate caused a temporary delay in subsequent color development, but the amount of colored product previously generated in the cuvette remained unchanged during this delay. Moreover, the rate of colored product generation before and after the addition of ascorbate was similar.
We also established (8) that preincubation of peroxidase with hydrogen peroxide and ascorbate for various time periods prior to addition of DCD did not shorten the time lag for color development. Color was formed at a fixed time after the addition of DCD, and this interval was relatively independent of the preincubation time. Because DCD, HRP, and hydrogen peroxide all must be present for ascorbate to be consumed, the ascorbate is not acting as a substrate for HRP and does not directly reduce hydrogen peroxide. A TIme(minutes) Fig. 3 . Effect of ascorbate on the formation of colored product of the HRP-catalyzed oxidation of DCD Reaction mixtureas in Fig. 2A (no ascorbate) . We initiated the reaction by adding HAP (16.7 ug/L final concentration), then monitored the absorbance at 440 nm. Afterapproximately 45 s, we added ascorbate (final concentration40 .rmoVL). About I mmlater,the absorbanceat 440 nm beganto increase. The slope ofthe linescorrelating absorbance vstime were identical beforeandafter the addition of ascorbate mechanism consistent with all the data is shown in Figure  4 : ascorbate acts to reduce a colorless, oxidized DCD intermediate product back to DCD, with the concomitant oxidation of ascorbate to dehydroascorbate.
Effect of Ascorbate on the Enzyme Immunochromatographic Assay
Because ascorbate effectively delayed color formation for the HRP mediated oxidation of DCD in solution, we examined its effects in a one-step immunochromatographic assay. The results (Table 1) indicate that, at a fixed concentration of theophylline, increasing the concentrations of ascorbate in the enzyme/developer reagent results in longer delays before the appearance of color on the test strip. Also, the greater the theophylline concentration, the earlier the color
develops. An interesting aspect of the ascorbate clock is that the color develops first at the highest point of the coujugate binding and eventually ifils in the rest of the test strip ( Figure 5 ). Presumably the ascorbate is first depleted at the upper regions of the strip (8) and the color develops first where the ascorbate is depleted.
From these results we conclude that, by proper loading of the ascorbate in the developer reagent, an internal chemical clock can be designed that prevents the generation of color reaction products on the immunochromatographic strip until the capillary migration has been completed. Test strips were placed in 1 mL of enzyme/developerreagentthat contained theindicatedconcentrationsof ascorbate,to which had been added 12 L of a solution that contained the indicated concentrations of theophylline. Each value is the mean of twodeterminations.
Assay Optimization
Because quantification in enzyme immunochromatographic assays is a function of migration distance rather than enzyme activity, these systems are relatively insensitive to changes in enzyme or substrate concentrations (2) . We have observed that a 30% variation in ascorbate or glucose oxidase can be tolerated without detrimental effect on the assay system (data not shown).
Performance Validation of the One-Step Assay of Theophylline
Precision: Within-run precision was determined by assaying whole blood supplemented with four different concentrations of theophylline, 10 replicates each. Sample theophylline concentrations were chosen to be below (5.0 mg/L), at either end of (10 and 20 mg/L), and above (40 mgfL) the therapeutic range. To evaluate between-run reproducibility, two operators determined the theophylline concentrations of five replicates on three consecutive days. The precision of the one-step immunochromatographic assay was acceptable both within-run (CVs between 6.0% and 9.4%) and betweenrun (CVs between 6.0% and 8.0%) ( Table 2) 
Specificity:
We determined the specificity of the assay by adding structurally similar compounds or known theophylline metabolites to whole-blood samples containing a fixed amount of theophylline, then quantifying. As Table 4 indicates, the assay has excellent specificity for theophylline, and relatively high concentrations of structurally similar compounds do not substantially affect the clinical accuracy of the method.
Correlation studies with patients' samples: Theophylline in 39 clinical serum samples as quantified by the one-step enzyme immunochromatographic assay correlated well with results by the EMIT#{174} enzyme immunoassay (Syva Co., Palo Alto, CA) and the AccuLevel two-step immunochromatographic assay: r = 0.99 and 0.99, respectively (8) .
Because the one-step enzyme immunochromatographic assay requires no instrument and assays small amounts of blood (12 /LL), such as can be obtained from a finger stick, it is ideally suited for tests in the physician's office and other Table 3 
